Dr. Boccia talks about the importance of controlling costs in the current environment and how the bioT3 testing approach can help compared to other options.
Video Categories: PMO Interview with the Innovator Series: Volume 9Description: Dr. Boccia describes cases in which he uses CancerTREATMENT NGS+ in his clinical practice.
Video Categories: PMO Interview with the Innovator Series: Volume 9Dr. Boccia describes cases in which he uses CancerTYPE ID in his clinical practice.
Video Categories: PMO Interview with the Innovator Series: Volume 9Dr. Boccia compares CancerTYPE ID to other gene expression tests and reviews studies validating its accuracy and clinical utility.
Video Categories: PMO Interview with the Innovator Series: Volume 9Dr. Boccia describes the components of the bioT3 platform and its clinical utility in identifying tumor type and actionable targets for therapy.
Video Categories: PMO Interview with the Innovator Series: Volume 9Dr. Boccia addresses the problem of unclear diagnoses affecting approximately 15% of newly diagnosed patients with metastatic disease each year and the importance of an accurate diagnosis of tumor type in selecting the proper site-specific therapies.
Video Categories: PMO Interview with the Innovator Series: Volume 9